Abstract
The role of an antigenemia assay in the diagnosis and prediction of human cytomegalovirus (HCMV) disease in AIDS patients was evaluated. The clinical history of 62 patients with advanced HIV infection from whom a total of 248 blood samples were drawn and tested by the HCMV antigenemia assay was examined retrospectively. Between December 1992 and January 1994, 28 episodes of HCMV disease with organ involvement were recorded; the antigenemia assay was positive in 23 of them (82.1 %). In particular, this test was positive in 11 of 12 (91.6 %) first episodes and in 3 of 3 (100 %) recurrent episodes occurring in patients not receiving maintenance therapy. The same test was positive in 9 of 13 (69.2 %) recurrent episodes occurring in patients receiving maintenance therapy. The first occurrence of HCMV disease was always preceded by a positive antigenemia assay 2 and 4 months before diagnosis (in all 7 patients of the 7 for whom a blood sample was available before HCMV disease). A positive antigenemia test result was not always followed by organ involvement, but a high positive cell count (>100/200,000 polymorphonuclear leukocytes) strongly correlated with the appearance of HCMV disease in the following 1 to 3 months (100 % of cases). The antigenemia assay is a useful and reliable indirect method for the diagnosis and prediction of HCMV endorgan disease in severely and persistently immunocompromised AIDS patients.
Similar content being viewed by others
References
Heinemann MH: Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. American Journal of Medicine 1992, 92, Supplement 2A: 12–15.
Drew WL: Cytomegalovirus infection in patients with AIDS. Clinical Infectious Diseases 1992, 14: 608–615.
Jacobson MA, Cello JP, Sande MA: Cholestasis and disseminated cytomegalovirus disease in patients with the acquired immunodeficiency syndrome. American Journal of Medicine 1988, 84: 218–224.
Kim YS, Hollander H: Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clinical Infectious Diseases 1993, 17: 32–37.
Bushles WC, Mastre BJ, Tinker AJ, Strand V, Koretz SH, the Syntex Collaborative Ganciclovir Treatment Study Group: Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Reviews of Infectious Diseases 1988, 10, Supplement 3: 495–506.
Palestine AG, Polis MA, De Smet MD, Baird BF, Falloon J, Kovacs JA, Davey RT, Zurlo JJ, Zunich KM, Davis M, Hubbard L, Brothers R, Ferris FL, Chew E, Davis JL, Rubin BI, Mellow SD, Metcalf JA, Manischewitz J, Minor JR, Nussenblatt RB, Masur H, Lane C: A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Annals of Internal Medicine 1991, 115: 665–673.
Gleaves CA, Smith TF, Shuster EA, Pearson GR: Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. Journal of Clinical Microbiology 1985, 21: 217–221.
Van Der Bij W, Schirm J, Torensma R, Van Son WJ, Tegzess AM, The TH: Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. Journal of Medical Virology 1988, 25: 179–188.
Revello MG, Percivalle E, Zavattoni M, Parea M, Grossi P, Gerna G: Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients. Journal of Medical Virology 1989, 29: 88–93.
Van Der Bij W, Schirm J, Torensma R, Van Son WJ, Tegzess AM, The TH: Comparison between viremia and antigenemia for the detection of cytomegalovirus in blood. Journal of Clinical Microbiology 1988, 26: 2531–2535.
Erice A, Holm MA, Gill PC, Henry S, Dirksen CL, Dunn DL, Hillam RP, Balfour HH: Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. Journal of Clinical Microbiology 1992, 30: 2822–2825.
Meyers JD, Ljungman P, Fisher LD: Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. Journal of Infectious Diseases 1990, 162: 373–380.
Salmon D, Lacassin F, Harzic M, Leport C, Perronne C, Bricaire F, Brun-Vezinet F, Vilde JL: Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. Journal of Medical Virology 1990, 32: 160–163.
Ehrnst A, Barkholt L, Brattström C, Czajkowski J, Teodosiu O, Tollemar J, Ljungman P: Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease. Journal of Medical Virology 1993, 39: 118–124.
Van Den Berg AP, Klompmaker IJ, Haagsma EB, Scholten-Sampson A, Bijlveid CMA, Shirm J, Van Der Giessen M, Slooff MJH, The TH: Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. Journal of Infectious Diseases 1991, 164: 265–270.
Koskinen PK, Nieminen MS, Mattila SP, Häyri PJ, Lautenschlager IT: The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 1993, 55: 547–551.
Gerna G, Zipeto D, Parea M, Percivalle E, Zavattoni M, Gaballo A, Milanesi G: Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia. Molecular and Cellular Probes 1991, 5: 365–374.
Gerna G, Percivalle E, Revello MG, Morini F: Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. Clinical Diagnostic Virology 1993, 1: 47–59.
Redfield RR, Wright DC, Tramonte C: The Walter Reed staging classification for HTLV III/LAV infection. New England Journal of Medicine 1986, 314: 131–132.
Keh WC, Gerber MA: In situ hybridization for cytomegalovirus DNA in AIDS patients. American Journal of Pathology 1988, 131: 490–496.
Revello MG, Percivalle E, Di Matteo A, Morini F, Gerna G: Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. Journal of General Virology 1992, 73: 437–442.
Grefte JMM, Van Der Gun BTF, Schmolke S, Van Der Giessen M, Van Son WJ, Plachter B, Jahn G, The TH: Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein pp65. Journal of Infectious Diseases 1992, 166: 683–684.
The TH, Van Der Ploeg M, Van Den Berg AP, Vlieger AM, Van Der Giessen M, Van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes — a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992, 54: 193–198.
Van Den Berg AP, Van Der Bij W, Van Son WJ, Anema J, Van Der Giessen M, Schirm J, Tegzess AM, The TH: Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation — a report of 130 consecutive patients. Transplantation 1989, 48: 991–995.
Boland GJ, De Gast GC, Hené RT, Jambroes G, Doncker Wolcke R, The TH, Mudde GC: Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. Journal of Clinical Microbiology 1990, 28: 2069–2075.
Zurlo JJ, O'Neill D, Polis MA, Manischewitz J, Yarcnoan R, Baseler M, Lane HC, Masur H: Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Annals of Internal Medicine 1993, 118: 12–17.
Fay MT, Freeman WR, Wiley CA, Hardy D, Bozzette S: Atypical retinitis in patients with the acquired immunodeficiency syndrome. American Journal of Ophthalmology 1988, 105: 483–490.
Gallant JE, Moore RD, Chaisson RE: Prophylaxis for opportunistic infections in patients with HIV infection. Annals of Internal Medicine 1994, 120: 932–944.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francisci, D., Tosti, A., Preziosi, R. et al. Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis. 14, 498–503 (1995). https://doi.org/10.1007/BF02113427
Issue Date:
DOI: https://doi.org/10.1007/BF02113427